UHS logo

UHS Universal Health Services, Inc. - Ordinary Shares - Class B

$175.00
$0.07
(0.04%)
Pre-Market
38

Bearish Sentiment

How do you feel about UHS?

Loading...
Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?
Tenet Healthcare's stronger cash flow is fueling bigger buybacks, but growth investments and capital needs will test how sustainable its strategy is.
Zacks
Implied Volatility Surging for Universal Health Services Stock Options
Investors need to pay close attention to UHS stock based on the movements in the options market lately.
Zacks
Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
HCA's rising admissions and shorter hospital stays could help it meet growing patient demand while using existing capacity more efficiently.
Zacks
Can Tenet Healthcare Sustain Growth Despite Lower Surgical Volumes?
THC's revenue growth persists despite softer surgical volumes, driven by higher revenue per case, acuity and favorable service mix.
Zacks
How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow
ACHC is converting capacity expansion into stronger cash flow as new facilities mature, patient volumes rise and capital spending stays disciplined.
Zacks
Can Operational Resiliency Protect HCA's Long-Term Profitability?
HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.
Zacks
Why Is Universal Health Services (UHS) Up 5.7% Since Last Earnings Report?
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES PR Newswire KING OF PRUSSIA, Pa., Aug. 25, 2026 KING OF PRUSSIA, Pa., Aug. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE...
PR Newswire
Universal Health Shares Drop 21% YTD: Should You Buy Now?
UHS' 21% YTD slide has cheapened its valuation, but weaker volumes, ACA pressure and lower growth forecasts keep risks elevated.
Zacks